Annual ROA
-16.77%
+5.65%+25.20%
31 December 2023
Summary:
Sarepta Therapeutics annual return on assets is currently -16.77%, with the most recent change of +5.65% (+25.20%) on 31 December 2023. During the last 3 years, it has fallen by -3.11% (-22.77%). SRPT annual ROA is now -262.99% below its all-time high of -4.62%, reached on 31 December 2011.SRPT ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROA
3.67%
+2.21%+151.37%
30 September 2024
Summary:
Sarepta Therapeutics quarterly return on assets is currently 3.67%, with the most recent change of +2.21% (+151.37%) on 30 September 2024. Over the past year, it has increased by +20.75% (+121.49%). SRPT quarterly ROA is now at all-time high.SRPT Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SRPT ROA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +121.5% |
| 3 y3 years | -22.8% | +125.1% |
| 5 y5 years | +59.4% | +109.1% |
SRPT ROA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -22.8% | +25.2% | at high | +110.1% |
| 5 y | 5 years | -22.8% | +59.4% | at high | +109.1% |
| alltime | all time | -263.0% | +90.9% | at high | +101.4% |
Sarepta Therapeutics ROA History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | 3.67%(+151.4%) |
| June 2024 | - | 1.46%(+170.4%) |
| Mar 2024 | - | 0.54%(-103.2%) |
| Dec 2023 | -16.77%(-25.2%) | -17.08%(-23.0%) |
| Sept 2023 | - | -22.17%(-24.4%) |
| June 2023 | - | -29.34%(-19.0%) |
| Mar 2023 | - | -36.21%(+59.4%) |
| Dec 2022 | -22.42%(+64.1%) | -22.71%(-4.7%) |
| Sept 2022 | - | -23.84%(+37.6%) |
| June 2022 | - | -17.32%(+39.8%) |
| Mar 2022 | - | -12.39%(-15.3%) |
| Dec 2021 | -13.66%(-40.7%) | -14.62%(-16.1%) |
| Sept 2021 | - | -17.42%(-22.2%) |
| June 2021 | - | -22.38%(-8.7%) |
| Mar 2021 | - | -24.51%(+18.7%) |
| Dec 2020 | -23.05%(-44.2%) | -20.65%(-16.5%) |
| Sept 2020 | - | -24.74%(+3.6%) |
| June 2020 | - | -23.88%(-25.8%) |
| Mar 2020 | - | -32.20%(-20.0%) |
| Dec 2019 | -41.28%(+68.2%) | -40.27%(+7.0%) |
| Sept 2019 | - | -37.64%(+2.7%) |
| June 2019 | - | -36.64%(+33.3%) |
| Mar 2019 | - | -27.48%(+1.4%) |
| Dec 2018 | -24.54%(+319.5%) | -27.09%(+29.1%) |
| Sept 2018 | - | -20.98%(-1.0%) |
| June 2018 | - | -21.19%(+8.8%) |
| Mar 2018 | - | -19.47%(+168.6%) |
| Dec 2017 | -5.85%(-92.4%) | -7.25%(-66.3%) |
| Sept 2017 | - | -21.54%(-27.9%) |
| June 2017 | - | -29.88%(-10.9%) |
| Mar 2017 | - | -33.53%(-59.8%) |
| Dec 2016 | -76.59%(-1.0%) | -83.38%(-6.6%) |
| Sept 2016 | - | -89.30%(-17.1%) |
| June 2016 | - | -107.74%(+13.2%) |
| Mar 2016 | - | -95.19%(+6.3%) |
| Dec 2015 | -77.36%(+67.1%) | -89.59%(+14.2%) |
| Sept 2015 | - | -78.45%(+26.3%) |
| June 2015 | - | -62.09%(+7.9%) |
| Mar 2015 | - | -57.53%(+28.6%) |
| Dec 2014 | -46.30%(+2.7%) | -44.72%(+36.4%) |
| Sept 2014 | - | -32.79%(-19.2%) |
| June 2014 | - | -40.58%(+3.2%) |
| Mar 2014 | - | -39.32%(-17.3%) |
| Dec 2013 | -45.10%(-51.8%) | -47.53%(-45.9%) |
| Sept 2013 | - | -87.93%(-31.1%) |
| June 2013 | - | -127.56%(-5.4%) |
| Mar 2013 | - | -134.84%(-10.8%) |
| Dec 2012 | -93.53%(+1924.5%) | -151.16%(+28.3%) |
| Sept 2012 | - | -117.83%(+335.8%) |
| June 2012 | - | -27.04%(-29.7%) |
| Mar 2012 | - | -38.47%(+840.6%) |
| Dec 2011 | -4.62%(-92.4%) | -4.09%(-73.2%) |
| Sept 2011 | - | -15.28%(-30.9%) |
| June 2011 | - | -22.11%(-63.5%) |
| Mar 2011 | - | -60.65%(-2.6%) |
| Dec 2010 | -60.71% | -62.27%(+64.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2010 | - | -37.85%(-10.0%) |
| June 2010 | - | -42.05%(-16.1%) |
| Mar 2010 | - | -50.11%(-12.2%) |
| Dec 2009 | -58.81%(-21.2%) | -57.10%(-27.3%) |
| Sept 2009 | - | -78.57%(-11.0%) |
| June 2009 | - | -88.33%(+186.7%) |
| Mar 2009 | - | -30.81%(-58.4%) |
| Dec 2008 | -74.65%(+9.2%) | -74.05%(-10.4%) |
| Sept 2008 | - | -82.60%(-2.5%) |
| June 2008 | - | -84.75%(-18.2%) |
| Mar 2008 | - | -103.62%(+21.8%) |
| Dec 2007 | -68.35%(+7.0%) | -85.09%(-8.9%) |
| Sept 2007 | - | -93.37%(+16.8%) |
| June 2007 | - | -79.92%(+18.9%) |
| Mar 2007 | - | -67.19%(+11.4%) |
| Dec 2006 | -63.89%(+62.7%) | -60.32%(+14.0%) |
| Sept 2006 | - | -52.90%(+17.7%) |
| June 2006 | - | -44.96%(+6.8%) |
| Mar 2006 | - | -42.11%(+6.4%) |
| Dec 2005 | -39.27%(-40.0%) | -39.58%(-13.7%) |
| Sept 2005 | - | -45.85%(-17.2%) |
| June 2005 | - | -55.40%(-7.2%) |
| Mar 2005 | - | -59.69%(-7.5%) |
| Dec 2004 | -65.49%(+69.7%) | -64.53%(+13.1%) |
| Sept 2004 | - | -57.04%(+5.9%) |
| June 2004 | - | -53.84%(+9.8%) |
| Mar 2004 | - | -49.03%(+16.6%) |
| Dec 2003 | -38.59%(-59.0%) | -42.05%(-14.7%) |
| Sept 2003 | - | -49.28%(-13.4%) |
| June 2003 | - | -56.90%(-25.5%) |
| Mar 2003 | - | -76.41%(-8.5%) |
| Dec 2002 | -94.07%(+20.4%) | -83.49%(+0.5%) |
| Sept 2002 | - | -83.08%(-18.5%) |
| June 2002 | - | -101.89%(+17.5%) |
| Mar 2002 | - | -86.75%(+10.7%) |
| Dec 2001 | -78.15%(+102.9%) | -78.33%(+10.1%) |
| Sept 2001 | - | -71.12%(+86.8%) |
| June 2001 | - | -38.08%(-9.7%) |
| Mar 2001 | - | -42.16%(+6.1%) |
| Dec 2000 | -38.51%(-46.4%) | -39.75%(-21.8%) |
| Sept 2000 | - | -50.82%(-40.0%) |
| June 2000 | - | -84.76%(+1.2%) |
| Mar 2000 | - | -83.78%(-18.0%) |
| Dec 1999 | -71.86%(-61.0%) | -102.22%(-0.7%) |
| Sept 1999 | - | -102.98%(-60.7%) |
| June 1999 | - | -261.95%(+23.9%) |
| Mar 1999 | - | -211.39%(+18.2%) |
| Dec 1998 | -184.14%(+488.3%) | -178.91%(+19.4%) |
| Sept 1998 | - | -149.82%(+461.8%) |
| June 1998 | - | -26.67%(-5.6%) |
| Mar 1998 | - | -28.24%(+29.2%) |
| Dec 1997 | -31.30%(-37.4%) | -21.85%(+21.2%) |
| Sept 1997 | - | -18.03%(+25.1%) |
| June 1997 | - | -14.41%(+77.7%) |
| Mar 1997 | - | -8.11% |
| Dec 1996 | -50.00% | - |
FAQ
- What is Sarepta Therapeutics annual return on assets?
- What is the all time high annual ROA for Sarepta Therapeutics?
- What is Sarepta Therapeutics quarterly return on assets?
- What is the all time high quarterly ROA for Sarepta Therapeutics?
- What is Sarepta Therapeutics quarterly ROA year-on-year change?
What is Sarepta Therapeutics annual return on assets?
The current annual ROA of SRPT is -16.77%
What is the all time high annual ROA for Sarepta Therapeutics?
Sarepta Therapeutics all-time high annual return on assets is -4.62%
What is Sarepta Therapeutics quarterly return on assets?
The current quarterly ROA of SRPT is 3.67%
What is the all time high quarterly ROA for Sarepta Therapeutics?
Sarepta Therapeutics all-time high quarterly return on assets is 3.67%
What is Sarepta Therapeutics quarterly ROA year-on-year change?
Over the past year, SRPT quarterly return on assets has changed by +20.75% (+121.49%)